The formation of the bilirubin oxidation products (BOXes), BOX A ([4-methyl-5-oxo-3-vinyl-(1,5-dihydropyrrol-2-ylidene)acetamide]) and BOX B (3-methyl-5-oxo-4-vinyl-(1,5-dihydropyrrol-2-ylidene)acetamide), as well as MVM (4-methyl-3-vinylmaleimide) were synthesized by oxidation of bilirubin with H 2 O 2 without and with FeCl 3 , respectively. Compound identity was confirmed with NMR and mass spectrometry (MS; less than 1 ppm, tandem MS up to MS 4 ). UV absorption profiles, including λ max , and extinction coefficient (ε; estimated using NMR) for BOX A, BOX B, and MVM in H 2 O, 15% CH 3 CN plus 10 mM CF 3 CO 2 H, CH 3 CN, CHCl 3 , CH 2 Cl 2 , and 0.9% NaCl were determined. At longer wavelengths, λ max 's for 1) BOX A were little affected by the solvent, ranging from 295-297 nm; 2) BOX B, less polar solvent yielded λ max 's of lower wavelength, with values ranging from 308-313 nm, and 3) MVM, less polar solvent yielded λ max 's of higher wavelength, with values ranging from 318-327 nm. Estimated ε's for BOX A and BOX B were approximately 5-to 10-fold greater than for MVM.
Specifications Table

Subject area
Chemistry More specific subject area Bilirubin oxidation products detection Type of data Table, figure How data was acquired NMR, mass spectroscopy, UV spectrometry, HPLC Data format Raw, analyzed
Experimental factors
Oxidation of bilirubin, extraction with chloroform
Experimental features
Bilirubin oxidation products BOX A, BOX B, and MVM were synthesized by the oxidation of bilirubin, purified by HPLC and UV absorption profiles and extinction coefficients determined Data source location Cincinnati, OH USA Data accessibility
The data are accessible within the article.
Value of the data
First report (to our knowledge) of UV absorption profile, including λ max , of MVM in solvents relevant to detection in biologic/pathobiologic samples.
Comparison of UV absorption profiles of MVM with BOX A and BOX B.
First report (to our knowledge) of BOX B extinction coefficient (ε; estimated using NMR), along with comparison to BOX A and MVM estimated ε's in different solvents, along with MS at less than 1 ppm and tandem MS up to MS 4 .
Novel methodology to increase MVM yield through FeCl 3 inclusion in oxidation reaction mixture. Data will potentially assist in the detection and determination of these BOXes in pathobiologies associated with elevated bilirubin.
Data
The bilirubin oxidation products (BOXes), MVM (4-methyl-3-vinylmaleimide), along with BOX A ([4-methyl-5-oxo-3-vinyl-(1,5-dihydropyrrol-2-ylidene)acetamide]) and BOX B (3-methyl-5-oxo-4-vinyl-(1,5-dihydropyrrol-2-ylidene)acetamide), have been implicated in the deleterious effects associated with subarachnoid hemorrhage (SAH; [1] [2] [3] [4] [5] ). The detection method utilized to determine the presence of these compounds is UV absorption associated with reversed phase-HPLC [1] . However, reports (to our knowledge) of the UV absorption profile and/or λ max of MVM have not been reported for the solvent utilized in their detection (H 2 O/CH 3 CN), but are limited to CH 3 OH [6, 7] . Also, reports of these absorption characteristics are limited (to our knowledge) for BOX A to H 2 O and CH 3 CN, and for BOX B to H 2 O [1, 8] . Further, extinction coefficients (ε) for MVM and BOX A are limited (to our knowledge) to CH 3 OH and CH 3 CN, respectively [6, 7, 9] , and are lacking for BOX B. Thus, it is anticipated that the present data will assist in the detection and quantitative determination of BOXes levels in biologic samples from SAH, as well as in other pathobiologies associated with elevated bilirubin.
UV absorption
UV absorption spectra of BOX A, BOX B and MVM were determined in CHCl 3 , CH 2 Cl 2 , CH 3 CN, 15% CH 3 CN plus 10 mM CF 3 CO 2 H, H 2 O, and 0.9% NaCl (Fig. 1, Table 1 ). At longer wavelengths, BOX A λ max 's were little affected by the solvent, ranging from 295-297 nm (Fig. 1, Table 1 ). With BOX B, less polar solvent yielded λ max 's of lower wavelength, with values ranging from 308-313 nm (Fig. 1, Table 1 ). With MVM, less polar solvent yielded λ max 's of higher wavelength, with values ranging from 318-327 nm (Fig. 1 
Extinction coefficients (ε)
Calculated ε's for BOX A, BOX B, and MVM at their respective λ max 's in CHCl 3 , CH 2 Cl 2 , CH 3 CN, 15% CH 3 CN plus 10 mM CF 3 CO 2 H, H 2 O, and 0.9% NaCl, ranged from 10,600-13,000, 19,000-24,200, and 2,100-2,820 L/mol-cm respectively ( Table 1 ). The ε determined using the actual amount of Z-BOX A (complete chemical synthesis), at λ max 295 in CH 3 CN, was 17,000 L/mol-cm [9] . Thus, the present Box A ε likely represents a low estimate ( Table 1 ). The estimated MVM ε (Table 1 ) is similar to that reported for MVM at λ max 317 and 319 nm in CH 3 OH of 2,300 and 2,290 L/mol-cm [6, 7] . 
Synthesis
Bilirubin solubilization was performed at room temperature in an aluminum foil wrapped vessel due to the reported light sensitivity of BOX A, BOX B, and MVM [1, 8, 10] . One or more 50 mg portions of bilirubin were incubated in 25 ml 0.2 M NaOH(aq) with occasional vortexing over 24-72 h [1, 10] . The dark red bilirubin solution was then buffered by addition of 7.5 ml of 0.5 M Tris base before neutralization with 0.4 ml of 12.3 M HCl(aq) to pH 7.0. Overtitration of the dark red solution to lower pH resulted in a green solution. The neutralized (pH 7) buffered bilirubin solution was immediately used for oxidation with H 2 O 2 . With prolonged storage, bilirubin precipitated from this supersaturated solution.
As performed under dim ambient light and in an unlit fume hood (and with dim ambient light) the neutral buffered solution (now in 0.1 M TrisHCl, pH 7.0, 0.15 M NaCl) was oxidized for 24 h with 8% H 2 O 2 (final concentration). For MVM synthesis, 0.5 M FeCl 3 was added (novel procedure) to the bilirubin solution prior to H 2 O 2 and the oxidation allowed to proceed for 10 min. Each aqueous reaction mixture (about 45 ml per 50 mg bilirubin) was extracted twice with 6 ml CHCl 3 or CH 2 Cl 2 (recoveries of BOX A, BOX B, and MVM were similar with CHCl 3 and CH 2 Cl 2 ) and the combined organic phase extracted once with 1 ml water, evaporated to~2 ml at o50°C and atmospheric pressure, transferred to microfuge tubes, and evaporated to near dryness. Additional~2 ml aliquots of extract were repeatedly added, each followed by evaporation to near dryness. The final addition of washed extract was evaporated to dryness and reconstituted in 1 ml 1% CH 3 CN(aq) for purification by reversed phase (RP)-HPLC.
Purification by RP-HPLC
RP-HPLC (0.1 cm light path; Shimadzu LC-10AT, Shimadzu Scientific Instruments, Columbia, MD) was used for both purification and analysis of the bilirubin oxidation products. As performed under dim light, organic solvent extracts of BOX A and BOX B, as well as MVM, reconstituted in 1% CH 3 CN (aq) were diluted as necessary into the RP-HPLC starting buffer of 2% CH 3 CN:98% H 2 O (v:v) containing 10 mM M CF 3 CO 2 H. Injections of 1.0-1.5 ml were made onto a Vydac 218TP C-18 5 µm column (250 × 4.6 mm) with guard column equilibrated with 2% CH 3 The column was eluted (1 ml/min) with a continuous gradient of 0.5% CH 3 CN/min (2% to 18% CH 3 CN) over 32 min, followed by steeper gradients and higher CH 3 CN concentration for washing the [6] . Present yields are generally consistent with earlier reports of o5% and 4% formation of BOX A, BOX B and MVM [1, 10] . While one of these reports [1] also demonstrated significant MVM synthesis (MVM:BOX A:BOX B ¼ 2.8:1:0.9; determined at 320 nm and as presently calculated with BOX A set to unity), the increased MVM formation was possibly due to a somewhat greater H 2 O 2 concentration in the reaction mixture with bilirubin (13% H 2 O 2 ). On the other hand, highly variable amounts of MVM were formed by oxidation of bilirubin with~10% H 2 O 2 [10] . Hydrogen peroxide oxidation of biliverdin instead of bilirubin did not increase the yield of MVM.
Stability
After purification, BOX A, BOX B, and MVM samples shielded with aluminum foil from light were stable for at least 6 mo at −20°C and for 24 h at room temperature in 14.6% CH 3 CN (eluting solvent), as determined by RP-HPLC; i.e., no loss of compound or detection of additional absorption peaks through the UV absorption spectrum. Removal of the aluminum foil and exposure of BOX A, BOX B, and MVM (in 14.6% CH 3 CN in a clear polypropylene microfuge tube) to ambient light for 24 h decreased recovery by 10%, 15%, and 5%, respectively, and the appearance of peaks at 18.3 min and 20.8 min with a ratio 1.13:1, and with λ max 's of 288 and 296 nm, respectively. Absorption was determined at 223 nm (upper trace) and at the respective λ max 's of BOX A, BOX B, and MVM, which were 297 (second most upper trace), 310 (third most upper trace), and 327 nm (lower trace), respectively (see Fig. 1 and Table 1 ).
UV absorption spectrometry
UV spectra were performed in a SpectraMax M5 (Molecular Devices, Sunnyvale, CA, USA).
1 H-NMR
For compound identification and ε determinations, analytic samples of BOX A, BOX B, and MVM (CHCl 3 extraction) were loaded onto a C 18 separation cartridge (Sep-Pak), washed with 1 ml D 2 O and eluted with 1.5 ml, 80% CD 3 CN (in D 2 O). Samples were then evaporated to dryness under N 2 and reconstituted in 1 ml CD 3 CN. BOX A, BOX B, and MVM chemical shifts and coupling constants were determined on a DMX-500. Extinction coefficients (ε) at the respective λ max 's for BOX A, BOX B, and MVM were determined by titration in CH 3 OH (3.49 ppm singlet) and integration of signals relative to CH 3 OH under conditions of long recycle delay, and determination of UV absorption.
1 H-NMR spectroscopy yielded chemical shifts and coupling constants for BOX A, BOX, B, and MVM consistent with previous reports ( Fig. 3 ; Table 2 ; [1, 6, 9] ).
MS
Samples for MS were prepared by evaporation of compounds in aqueous CH 3 CN to dryness in an N 2 stream at 40°C, followed by reconstitution in 10% CH 3 Table 3 .
Lyophylization was avoided due to apparent loss of compounds. Samples obtained from RP-HPLC were infused into a Thermo Scientific LTQ-FT™ hybrid MS consisting of a linear ion trap and a Fourier transform ion cyclotron resonance (FT-ICR) MS. The standard electrospray ionization (ESI) source was operated in a profile mode for both positive and negative ions as indicated (Fig. 4 , Table 3 ). The only possible elemental composition at 2 ppm mass error, but also even at 5 ppm, for 0-10 nitrogen, 0-15 oxygen, 0-30 carbons, and 0-60 hydrogens are those of BOX A and BOX B (as assessed for the positive ion mode), and for MVM (as assessed in both the positive and negative ion mode; Fig. 4 , Table 3 ; consistent with 1,6,9,10). With MVM as the protonated molecular ion, the observed mass was m/z 138.05498 with a mass error of 180 ppb. For MVM, MS also suggested the apparent presence of the plastic antioxidant/stabilizer 1,10-bis(2,2,6,6-tetramethyl-4-piperidinyl-decanedioate), resulting from the (initial) carrying out of the FeCl 3 -bilirubin-H 2 O 2 oxidation in a polypropylene vessel ("2. Experimental design, materials and methods; 2.1. Synthesis"; subsequent oxidations were performed in glass containers). 
